Targeted delivery of immuno-RNase may improve cancer therapy

BACKGROUND: Immunotoxins are typical therapeutic drugs that can target cancer cells. They exploit the affinity of specific monoclonal antibodies or ligands to cancer cells to deliver a conjugated protein toxin to target sites, thus, attacking the cancer cells. METHODS: The immuno-RNase, Onc-V3, show...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Miaonan, Sun, Liankun, Sun, Dejun, Zhang, Chunmei, Li, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902972/
https://www.ncbi.nlm.nih.gov/pubmed/29686536
http://dx.doi.org/10.1186/s12935-018-0546-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902972/
https://www.ncbi.nlm.nih.gov/pubmed/29686536
http://dx.doi.org/10.1186/s12935-018-0546-7

Ejemplares similares